Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Warner Bros. Veteran Jeffrey Schlesinger Joins Kartoon Studios Board of Directors
-
Fast track to career success: CIAT and CompTIA offer innovative tech training and certification program
-
Nukkleus Inc. Announces Filing of Corporate-Sponsored SPAC Registration Statement
-
Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025
-
WeightWatchers Launches RxFlexFund™, a New Employer Model for Expanding GLP-1 Coverage
-
TRX Staking Now Available on Ledger Live through Yield.xyz
-
Brazil Potash Announces $28 Million Private Placement
-
24/7 Market News: VENU Hits High Notes as Sunset Amphitheater Momentum Sparks Next Phase
-
The Board of AB Nasdaq Vilnius adopted the decision to delist the shares of PST Group AB from trading on regulated market
-
Decisions adopted at the Extraordinary General Meeting of Shareholders of LITGRID AB
-
Freddie Mac Announces Results of Tender Offer for Certain STACR Notes
-
Great Estate Blockchain (OTC: VAYK) to Launch Solution Unlocking $1 Trillion Dormant Asset
-
Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show
-
LiquidTrust’s Protected Pay Named Silver Medalist in 2025 Datos Impact Awards in Commercial Banking & Payments
-
Vocodia Holdings Corp. and Scale Agile Solutions Announce Letter of Intent for Strategic Asset Acquisition
-
Linkers Industries Limited Announces Entry into a Material Definitive Agreement
-
RocketFuel Launches Comprehensive Crypto Invoicing Solution for Global Merchants
-
Dolphin Liberty 600 by Maytronics Named to TIME’s List of the Best Inventions of 2025
-
Freight Technologies Launches AI-Powered Automated Invoice Validation in Fleet Rocket TMS and Fr8app Platforms
-
Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week
-
Hain Celestial Announces Fiscal 2026 First Quarter Earnings Results Conference Call and Webcast
-
LiquidTrust’s Protected Pay Named Silver Medalist in 2025 Datos Impact Awards in Commercial Banking & Payments
-
Cellebrite to Report Third-Quarter 2025 Financial Results on November 12, 2025
-
Security-First Networking Delivers 60% Cost Savings, New Analysis Reveals
-
More than eight in 10 Canadians Support a “Buy Canadian” Mandate Requiring Government Advertising Spending to Support Canadian-Owned Media Companies and Platforms
-
OBOOK Holdings Inc. Announces Successful Direct Listing on Nasdaq
-
Coinbase Asset Management & iTrustCapital Partner on Bitcoin Yield Strategy for IRAs
-
Coinbase Asset Management & iTrustCapital Partner on Bitcoin Yield Strategy for IRAs
-
24/7 Market News- Kraig Labs Spider Silk Poised to Lead the Sustainable Textile Revolution
-
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Hertz Global Holdings, Inc. (NASDAQ: HTZ): Grab
-
Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
-
CSW Industrials Declares Quarterly Dividend of $0.27 Per Share
-
SoundThinking Unveils CrimeTracer Gen3: Expanding from Investigations to Agency-Wide Crime Data Solution
-
BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways
-
Vystar’s Vytex® Cloud Bed-in-a-Box Available for Sale
-
CDT Equity Increases Bitcoin Holding
-
Genie Energy to Report Third Quarter 2025 Results
-
Nightfood Achieves $10 Million in Annualized Revenue, Strengthens Position for Uplisting
-
Five Below Makes Its Pacific Northwest Debut, Bringing Extreme Value to the Region With Eight New Stores
-
DeFi Development Corp. Publishes New Market Analysis: “The Next Best Crypto Trade? Solana DATs.”
-
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Results of General Meeting
-
BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways
-
Evaxion reports 75% Objective Response Rate in phase 2 trial with AI-designed personalized cancer vaccine EVX-01
-
Royalty Pharma Declares Fourth Quarter 2025 Dividend
-
IMUNON Invited to Present PlaCCine® DNA Technology Proof-of-Concept Data in Platform Presentations at Leading Vaccine Conferences
-
Proven Strength, New Chapters Ahead: Chery Super Hybrid (CSH) Global Endurance Test Concludes in Triumph, Paving the Way for the 2025 Chery Brand User Summit
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated (NYSE - CMA), Veeco Instruments
-
Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia
-
Manitoba Farmers: Safely Dispose of Unwanted Pesticides and Old Livestock/Equine Medications This October
